Written and maintained by CASRAI Editorial Board
Published
On this page
What it is
Frontiers in Cellular and Infection Microbiology is a peer-reviewed, fully gold open access academic journal launched in 2011 by Frontiers Media SA (Lausanne, Switzerland). Operating under Electronic ISSN 2235-2988 (abbreviated internationally as fcimb or Front. Cell. Infect. Microbiol.), the journal focuses on the molecular and cellular mechanisms by which pathogenic microbes interact with eukaryotic hosts. All articles publish under the Creative Commons Attribution 4.0 International License (CC BY 4.0), permitting unrestricted global distribution and reuse.
The journal is indexed in PubMed, MEDLINE, PubMed Central (PMC), Scopus, Clarivate’s Web of Science Science Citation Index Expanded (SCIE), and the Directory of Open Access Journals (DOAJ). Additional coverage includes Crossref, Biological Abstracts, Dimensions, and Embase. In citation metrics, the journal holds a Journal Impact Factor (JIF) of 5.5 and a Scopus CiteScore of 9.6. For details on how citation percentiles are evaluated, see our guide on journal impact factor and quartile rankings.
Ask CASRAI · free to tryQuestion about this guide? Ask CASRAI answers with linked sources. 2 free questions a day, no account.
Who runs it and what it covers
The journal is directed by Field Chief Editor Prof. Yousef Abu Kwaik of the University of Louisville (USA), supported by an international editorial board of Specialty Chief Editors, Associate Editors, and Review Editors.
Its scope encompasses all pathogenic microbes—bacteria, viruses, fungi, parasites, endosymbionts, and prions—alongside host immune defenses and microbial communities. Research is organized across 16 Specialty Sections:
- Adaptive and Innate Immunity in Infection: Receptor signaling, cytokine pathways, and host defenses.
- Antibiotic Resistance and New Antimicrobial Drugs: Drug resistance mechanisms, surveillance, and novel compounds.
- Bacteria and Host: Cellular interactions, tissue colonization, and bacterial physiological responses.
- Biofilms: Matrix architecture, microbial community dynamics, and biofilm persistence.
- Clinical Infectious Diseases: Pathophysiology and clinical presentations of human infectious diseases.
- Clinical and Diagnostic Microbiology and Immunology: Diagnostic assays and rapid pathogen identification.
- Extra-Intestinal Microbiome: Microbial ecology in respiratory, cutaneous, and urogenital niches.
- Fungal Pathogenesis: Virulence determinants and host interactions of pathogenic fungi.
- Intestinal Microbiome: Gut microbial ecology, dysbiosis, metabolomics, and host disease.
- Microbial Vaccines: Antigen design, adjuvant biology, and preclinical immunogenicity.
- Molecular Bacterial Pathogenesis: Secretion systems, toxins, intracellular survival, and gene regulation.
- Molecular Viral Pathogenesis: Viral replication cycles, host interfaces, and latency.
- Oral Microbes and Host: Oral ecology, periodontitis biology, and mucosal immunology.
- Parasite and Host: Protozoan and helminth pathogenesis, life cycles, and immune modulation.
- Veterinary and Zoonotic Infection: Cross-species transmission and animal infectious biology.
- Virus and Host: Cellular tropism, antiviral restriction factors, and viral pathology.
Manuscripts examining non-pathogenic organisms, non-microbial plant or animal models without infection biology, or pharmacology outside microbial systems are out of scope. Standalone bibliometric studies, Mendelian Randomization analyses, and purely computational surveys lacking cellular or microbiological laboratory validation are not accepted.
How to search or use it
Researchers interacting with the journal navigate the platform through six verified operational steps:
Step 1: Browse Articles and Collections
Readers access the official portal (https://www.frontiersin.org/journals/cellular-and-infection-microbiology) to review recent releases, search specialty sections, or explore thematic “Research Topics” (curated collections on emerging themes). Articles are freely accessible in HTML, PDF, and XML formats, and mirrored in PubMed Central.
Step 2: Prepare Submission Files
Authors format manuscripts using Harvard author-date citations, continuous line numbering, and high-resolution figures. The corresponding author registers or connects an ORCID profile through the Frontiers Loop platform.
Step 3: Select Submission Track
In the MyFrontiers submission interface, authors choose Frontiers in Cellular and Infection Microbiology, designate the appropriate Specialty Section, or link their paper to an active Research Topic call.
Step 4: Automated Integrity Screening with AIRA
Submitted manuscripts undergo automated screening via Frontiers’ Artificial Intelligence Review Assistant (AIRA). AIRA executes over 50 checks across text overlap, figure integrity, conflict disclosures, and ethical approvals before assignment to an editor.
Step 5: Participate in the Interactive Review Forum
The handling editor selects at least two independent expert reviewers for single-anonymized review. Once reports are submitted, the editorial system activates the online Frontiers Review Forum. Authors and reviewers interact directly in this portal to resolve technical critiques, clarify data, and upload revised drafts. This collaborative model is detailed in our guide to Frontiers collaborative peer review.
Step 6: Receive Endorsement and Publication
When reviewers endorse the paper, the Associate Editor recommends acceptance, subject to final validation by the Field Chief Editor. Authors arrange APC payment, and the final article publishes under CC BY 4.0 with the names of the handling editor and endorsing reviewers credited on the article.
Strengths and limits
Authors evaluating the journal should weigh its key operational strengths and limits:
- Strengths:
- Universal Access: Immediate CC BY 4.0 open-access dissemination enables global readership without subscription walls.
- Comprehensive Indexing: Full coverage in MEDLINE, PubMed Central, Scopus, and SCIE meets funder open-access mandates.
- Collaborative Review Forum: Direct online interaction between authors and reviewers reduces revision turnaround times.
- Reviewer Transparency: Listing endorsed reviewers on accepted articles provides public accountability.
- Competitive Impact: A 5.5 JIF and 9.6 CiteScore place it prominently among specialized infection biology journals.
- Limits:
- Article Processing Charges: Authors without institutional waivers or funding must cover mandatory fees (CHF 3,150 for research articles). For context, see our overview of article processing charges (APCs).
- Mandatory Experimental Validation: Purely in silico analyses without laboratory cellular validation face desk rejection.
- Section Granularity: 16 distinct tracks require authors to select the correct section to avoid reassignment delays.
- Disclosed Reviewer Names: Public attribution of reviewers on published articles may discourage reviewers on sensitive topics.
Alternatives
The table below compares Frontiers in Cellular and Infection Microbiology with peer journals in infection biology:
| Journal | Publisher | Publishing Model | Citation Metrics | Peer Review Format | Scope Focus |
|---|---|---|---|---|---|
| Frontiers in Cellular and Infection Microbiology | Frontiers Media SA | Fully Gold Open Access (CC BY 4.0; CHF 3,150 APC) | 5.5 JIF; 9.6 CiteScore | Single-anonymized; Interactive Review Forum; named reviewer credit | Microbial pathogens, host responses, and 16 specialty sections; excludes purely in silico papers. |
| Cell Host & Microbe | Cell Press / Elsevier | Hybrid / Transformative (Subscription / OA) | ~20.6 JIF; 34.0 CiteScore | Single- or double-anonymized; confidential review | High-impact mechanistic discoveries across host-microbe interactions. See our profile of Cell Host & Microbe. |
| PLOS Pathogens | PLOS | Fully Gold Open Access (CC BY 4.0; APC model) | ~5.5 JIF; 11.2 CiteScore | Single-anonymized; optional published peer review history | Original research on pathogens causing significant host disease. |
| Infection and Immunity | American Society for Microbiology (ASM) | Hybrid / Transformative (Subscription / OA) | ~2.9 JIF; 6.5 CiteScore | Single-anonymized peer review | Traditional society journal focused on bacterial, fungal, and parasitic infections and immunity. |
| mBio | American Society for Microbiology (ASM) | Fully Gold Open Access (CC BY 4.0; APC model) | ~5.1 JIF; 9.7 CiteScore | Single-anonymized peer review | Broad-scope microbiology covering high-priority studies across virology, bacteriology, and pathogenesis. |
FAQ
What is the impact factor of Frontiers in Cellular and Infection Microbiology?
The Frontiers in Cellular and Infection Microbiology impact factor is 5.5, as reported in Clarivate’s Journal Citation Reports (Web of Science SCIE). In Scopus, the journal holds a CiteScore of 9.6, reflecting consistent citation impact across infectious disease and cellular microbiology fields.
What are the publication fees (APCs) for Frontiers in Cellular and Infection Microbiology?
As a gold open-access publication, the journal assesses Article Processing Charges (APCs) in Swiss Francs (CHF) upon acceptance:
- Type A Articles: CHF 3,150 (Original Research, Systematic Review, Methods, Review, Technology and Code, Clinical Trial).
- Type B Articles: CHF 2,500 (Mini Review, Perspective, Brief Research Report, General Commentary, Opinion).
- Type C Articles: CHF 0 (Corrections and Editorials publish free).
Authors at partner institutions with institutional agreements receive central billing or discounts, and fee waivers are available for authors from low- and middle-income countries.
Is Frontiers in Cellular and Infection Microbiology indexed in PubMed and MEDLINE?
Yes. The journal is fully indexed in MEDLINE, PubMed, and PubMed Central (PMC). Full bibliographic citations appear in PubMed, and complete open-access full-text articles deposit in PMC upon release.
Does the journal accept purely computational or bioinformatic studies?
No. Editorial policy explicitly excludes manuscripts relying entirely on bibliometric analyses, Mendelian Randomization, or public dataset mining without cellular or microbiological experimental validation.
Who is the Field Chief Editor of the journal?
The Field Chief Editor is Prof. Yousef Abu Kwaik of the University of Louisville, USA, leading an international board across 16 specialty sections.
What copyright license applies to accepted articles?
Articles publish under the Creative Commons Attribution 4.0 International license (CC BY 4.0). Authors retain copyright, and readers can freely distribute or adapt the content with proper credit.
Sources
- Frontiers in Cellular and Infection Microbiology Journal Homepage — Official scope, 16 specialty sections, and schema metadata. Accessed November 11, 2026.
- Frontiers in Cellular and Infection Microbiology About and Indexing — Electronic ISSN 2235-2988, 5.5 Impact Factor, 9.6 CiteScore, and indexing list. Accessed November 11, 2026.
- Frontiers Fee Policy and Article Processing Charges — APC pricing tiers (Type A CHF 3,150; Type B CHF 2,500; Type C CHF 0) and waiver details. Accessed November 11, 2026.
- Frontiers Collaborative Review System — Overview of AIRA automated screening, single-anonymized review, and interactive review forum. Accessed November 11, 2026.
- Frontiers Peer Review Guidelines — Review stages, acceptance standards, and reviewer attribution rules. Accessed November 11, 2026.







